Literature DB >> 31873966

Gpr126/Adgrg6 contributes to the terminal Schwann cell response at the neuromuscular junction following peripheral nerve injury.

Albina Jablonka-Shariff1, Chuieng-Yi Lu1,2, Katherine Campbell3, Kelly R Monk4,5, Alison K Snyder-Warwick1.   

Abstract

Gpr126/Adgrg6 is an adhesion G protein-coupled receptor essential for Schwann cell (SC) myelination with important contributions to repair after nerve crush injury. Despite critical functions in myelinating SCs, the role of Gpr126 within nonmyelinating terminal Schwann cells (tSCs) at the neuromuscular junction (NMJ), is not known. tSCs have important functions in synaptic maintenance and reinnervation, and after injury tSCs extend cytoplasmic processes to guide regenerating axons to the denervated NMJ. In this study, we show that Gpr126 is expressed in tSCs, and that absence of Gpr126 in SCs (SC-specific Gpr126 knockout, cGpr126) results in a NMJ maintenance defect in the hindlimbs of aged mice, but not in young adult mice. After nerve transection and repair, cGpr126 mice display delayed NMJ reinnervation, altered tSC morphology with decreased S100β expression, and reduced tSC cytoplasmic process extensions. The immune response promoting reinnervation at the NMJ following nerve injury is also altered with decreased macrophage infiltration, Tnfα, and anomalous cytokine expression compared to NMJs of control mice. In addition, Vegfa expression is decreased in muscle, suggesting that cGpr126 non-cell autonomously modulates angiogenesis after nerve injury. In sum, cGpr126 mice demonstrated delayed NMJ reinnervation and decreased muscle mass following nerve transection and repair compared to control littermates. The integral function of Gpr126 in tSCs at the NMJ provides the framework for new therapeutic targets for neuromuscular disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Gpr126; NMJ; nerve injury; terminal Schwann cells

Year:  2019        PMID: 31873966      PMCID: PMC7148175          DOI: 10.1002/glia.23769

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  67 in total

1.  Effect of reinnervation on the degradation rate of junctional acetylcholine receptors synthesized in denervated skeletal muscles.

Authors:  S L Shyng; M M Salpeter
Journal:  J Neurosci       Date:  1990-12       Impact factor: 6.167

Review 2.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

3.  Motor axon regeneration and muscle reinnervation in young adult and aged animals.

Authors:  Hyuno Kang; Jeff W Lichtman
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

Review 4.  Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions.

Authors:  Y J Son; J T Trachtenberg; W J Thompson
Journal:  Trends Neurosci       Date:  1996-07       Impact factor: 13.837

5.  The adhesion GPCR GPR126 has distinct, domain-dependent functions in Schwann cell development mediated by interaction with laminin-211.

Authors:  Sarah C Petersen; Rong Luo; Ines Liebscher; Stefanie Giera; Sung-Jin Jeong; Amit Mogha; Monica Ghidinelli; M Laura Feltri; Torsten Schöneberg; Xianhua Piao; Kelly R Monk
Journal:  Neuron       Date:  2015-02-18       Impact factor: 17.173

Review 6.  International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

Authors:  Jörg Hamann; Gabriela Aust; Demet Araç; Felix B Engel; Caroline Formstone; Robert Fredriksson; Randy A Hall; Breanne L Harty; Christiane Kirchhoff; Barbara Knapp; Arunkumar Krishnan; Ines Liebscher; Hsi-Hsien Lin; David C Martinelli; Kelly R Monk; Miriam C Peeters; Xianhua Piao; Simone Prömel; Torsten Schöneberg; Thue W Schwartz; Kathleen Singer; Martin Stacey; Yuri A Ushkaryov; Mario Vallon; Uwe Wolfrum; Mathew W Wright; Lei Xu; Tobias Langenhan; Helgi B Schiöth
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells.

Authors:  Yongwei Qin; Chun Cheng; Haibo Wang; Xiaoyi Shao; Yongjing Gao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-01-17       Impact factor: 3.996

Review 8.  Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.

Authors:  Shambhunath Bose; Jungsook Cho
Journal:  Arch Pharm Res       Date:  2013-06-15       Impact factor: 4.946

9.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Hypothalamic Sirt1 protects terminal Schwann cells and neuromuscular junctions from age-related morphological changes.

Authors:  Alison K Snyder-Warwick; Akiko Satoh; Katherine B Santosa; Shin-Ichiro Imai; Albina Jablonka-Shariff
Journal:  Aging Cell       Date:  2018-05-30       Impact factor: 9.304

View more
  13 in total

Review 1.  Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair.

Authors:  Kathryn L Wofford; Robert B Shultz; Justin C Burrell; D Kacy Cullen
Journal:  Prog Neurobiol       Date:  2021-09-04       Impact factor: 11.685

Review 2.  Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.

Authors:  Trisha Lala; Randy A Hall
Journal:  Physiol Rev       Date:  2022-04-25       Impact factor: 46.500

3.  Macrophage-Derived Vascular Endothelial Growth Factor-A Is Integral to Neuromuscular Junction Reinnervation after Nerve Injury.

Authors:  Chuieng-Yi Lu; Katherine B Santosa; Albina Jablonka-Shariff; Bianca Vannucci; Anja Fuchs; Isaiah Turnbull; Deng Pan; Matthew D Wood; Alison K Snyder-Warwick
Journal:  J Neurosci       Date:  2020-11-06       Impact factor: 6.167

Review 4.  Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery.

Authors:  Rachel Rios; Albina Jablonka-Shariff; Curtis Broberg; Alison K Snyder-Warwick
Journal:  Mol Cell Neurosci       Date:  2021-01-08       Impact factor: 4.314

5.  T-box transcription factor 21 is expressed in terminal Schwann cells at the neuromuscular junction.

Authors:  Albina Jablonka-Shariff; Curtis Broberg; Rachel Rios; Alison K Snyder-Warwick
Journal:  Muscle Nerve       Date:  2021-05-12       Impact factor: 3.852

6.  Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice.

Authors:  Anna Henzi; Assunta Senatore; Asvin K K Lakkaraju; Claudia Scheckel; Jonas Mühle; Regina Reimann; Silvia Sorce; Gebhard Schertler; Klaus V Toyka; Adriano Aguzzi
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

7.  The prion protein is not required for peripheral nerve de- and remyelination after crush injury.

Authors:  Anna Henzi; Adriano Aguzzi
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 8.  Terminal Schwann Cell Aging: Implications for Age-Associated Neuromuscular Dysfunction.

Authors:  Sandra Fuertes-Alvarez; Ander Izeta
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

9.  Terminal Schwann cells at the human neuromuscular junction.

Authors:  Abrar Alhindi; Ines Boehm; Rachael O Forsythe; Janice Miller; Richard J E Skipworth; Hamish Simpson; Ross A Jones; Thomas H Gillingwater
Journal:  Brain Commun       Date:  2021-04-15

10.  Progress in perisynaptic Schwann cell and neuromuscular junction research.

Authors:  Chandler L Walker
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.